A gene responsible for producing a critical enzyme in inflammatory signalling has been identified after more than 30 years, ...
A hybrid microrobotic platform combining living bacteria, nanoparticles and targeted chemotherapy has achieved 82.4 percent ...
The right signals can make or break an organoid model. From growth and differentiation to downstream drug testing, cytokines and growth factors are critical to creating cultures researchers can rely ...
PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples to train ...
Cambridge biotech bit.bio has released ioAstrocytes 2.0, a genetically matched human astrocyte model designed to support ...
From self-driving laboratories to advanced cellular models, ELRIG Drug Discovery 2026 showcases technologies helping researchers generate better data, evaluate drug candidates and improve early ...
Researchers at Nagoya University have identified BCAT1, an enzyme involved in proline supply for collagen synthesis, as a ...
Researchers at the University of Birmingham have identified the P2X7 receptor as a key driver of neuroinflammation in human ...
TechBio firm WhiteLab Genomics has closed a $26 million Series B round to expand in vivo validation of its AI-designed ...
Poor recovery, inconsistent growth and changes in morphology can affect organoid research. How much experimental variability ...
Stability problems can derail promising biologics late in development. Bringing high-throughput testing earlier into ...
Researchers at Albert Einstein College of Medicine have identified a cellular recycling pathway whose age-related decline allows senescent 'zombie' cells to evade immune clearance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results